The role of prescription opioid and cannabis supply policies on opioid overdose deaths - Scorecard - MDSpire

The role of prescription opioid and cannabis supply policies on opioid overdose deaths

  • By

  • Magdalena Cerdá

  • Katherine Wheeler-Martin

  • Emilie Bruzelius

  • Christine M Mauro

  • Stephen Crystal

  • Corey S Davis

  • Samrachana Adhikari

  • Julian Santaella-Tenorio

  • Katherine M Keyes

  • Kara E Rudolph

  • Deborah Hasin

  • Silvia S Martins

  • July 18, 2024

  • 0 min

Share

Clinical Scorecard: Impact of Prescription Opioid and Cannabis Regulation on Opioid Overdose Mortality Rates

At a Glance

CategoryDetail
ConditionOpioid overdose mortality
Key MechanismsPrescription drug monitoring programs (PDMPs) with must-query mandates and legalization of medical and recreational cannabis supply
Target PopulationUnited States counties affected by opioid overdose deaths from 2013-2020
Care SettingPublic health and policy regulation settings

Key Highlights

  • Must-query PDMPs were associated with a small increase in opioid-involved overdose deaths (0.8 additional deaths per 100,000 person-years).
  • Legal cannabis supply alone was not independently associated with changes in opioid overdose deaths during the study period.
  • Must-query PDMPs enacted alongside legal cannabis supply were associated with more opioid overdose deaths compared to must-query PDMPs without legal cannabis.

Guideline-Based Recommendations

Diagnosis

  • Use PDMP data to identify patients at risk of opioid use disorder or overdose.

Management

  • Implement must-query PDMPs requiring prescribers to check prescription histories before prescribing opioids.
  • Consider the potential unintended consequences of stricter opioid prescribing policies, including increased use of illicit opioids.

Monitoring & Follow-up

  • Monitor opioid prescribing patterns and overdose mortality rates following PDMP implementation.
  • Track changes in opioid overdose deaths in relation to cannabis legalization policies.

Risks

  • Stricter opioid prescribing regulations may inadvertently increase demand for illicit opioids such as heroin and synthetic opioids.
  • Cannabis legalization did not reduce opioid overdose deaths in the studied period and may not mitigate risks associated with PDMP policies.

Patient & Prescribing Data

Patients prescribed opioids in states with must-query PDMPs and varying cannabis legalization statuses

Must-query PDMPs can modify prescribing practices but may not reduce opioid overdose mortality; cannabis legalization does not independently reduce overdose deaths.

Clinical Best Practices

  • Incorporate PDMP checks as a standard practice before prescribing controlled substances to identify high-risk patients.
  • Be aware of the potential for increased illicit opioid use following stricter prescription regulations.
  • Consider alternative pain management strategies, though cannabis legalization alone has not demonstrated reduction in opioid overdose deaths.
  • Continuously evaluate the impact of opioid prescribing policies and cannabis laws on overdose mortality to inform policy adjustments.

References

Original Source(s)

Related Content